Effect of the combined ingestion of plant-derived ingredients on the pharmacokinetic parameter
Not Applicable
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000043278
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 8
Inclusion Criteria
Not provided
Exclusion Criteria
1) history of or under treatment for gastrointestinal disorder 2) under treatment for severe disease 3) taking therapeutic medicine 4) TG > 399mg/dL, T-Cho > 259mg/dL, FBG 125mg/dL > and HbA1c > 6.4%, AST > 50U/L, ALT > 50U/L, g-GTP > 100U/L 5) HBs positive, HCV positive 6) creatinine > 1.29mg/dL, BUN > 22.0mg/dL 7) syphilis positive, HIV positive 8) food allergy 9) shift worker 10) blood donor (> 200 mL within the last month or > 400 mL within the last 3 months) 11) heavy drinker 12) heavy smoker 13) drinking less than 2 cups of tea or coffee per day 14) Subjects who are judged to be inappropriate for the study by the medical doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the pharmacokinetic parameter after the single ingestion. (AUC)
- Secondary Outcome Measures
Name Time Method Evaluation of the pharmacokinetic parameter after the single ingestion. (Cmax, Tmax)